Improving integrated care and systematically targeting major cancer and non‐cancer causes of morbidity and mortality could yield major benefits
Cancer is the leading cause of death and disability in Australia, and it is estimated that more than 1.6 million people were living with cancer at the end of 2015.1 Most of these people will live with the disease for many years; for all cancers combined, five‐year relative survival in 2012–2016 was about 69%.1 Although cancer is regarded by many people as a single condition, it is highly heterogeneous, with extreme variations in experiences and outcomes according to the type, aggressiveness, treatment, and stage of the cancer, and the age and comorbid conditions of the patient.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Australian Institute of Health and Welfare. Cancer data in Australia (Cat. vol no. CAN 122). Canberra: AIHW, 2020: https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia (viewed Mar 2021).
- 2. Koczwara B, Meng R, Miller M, et al. Late mortality in people with cancer: a population‐based Australian study. Med J Aust 2021; 214: 318–323.
- 3. Zaorsky NG, Churilla TM, Egleston BL, et al. Causes of death among cancer patients. Ann Oncol 2017; 28: 400–407.
- 4. Australian Institute of Health and Welfare. Australian Burden of Disease Study: impact and causes of illness and death in Australia 2015 (Australian Burden of Disease series no. 19; Cat. no. BOD 22); supplementary table S4.5. Canberra: AIHW, 2019. https://www.aihw.gov.au/getmedia/a67416f3-7713-43f0-b96b-a7ab3c104845/ABDS2015-detailed-report-supplementary-tables-final.xlsx.aspx (viewed Mar 2021).
- 5. Strongman H, Gadd S, Matthews A, et al. Medium and long‐term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population‐based cohort study using multiple linked UK electronic health records databases. Lancet 2019; 394: 1041–1054.
- 6. Baade PD, Fritschi L, Eakin EG. Non‐cancer mortality among people diagnosed with cancer (Australia). Cancer Causes Control 2006; 17: 287–297.
- 7. Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular disease events, and blood pressure‐ and lipid‐lowering therapy in Australia. Med J Aust 2016; 204: 320. https://www.mja.com.au/journal/2016/204/8/absolute-risk-cardiovascular-disease-events-and-blood-pressure-and-lipid
- 8. Weaver KE, Foraker RE, Alfano CM, et al. Cardiovascular risk factors among long‐term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv 2013; 7: 253–261.
- 9. National Center for Chronic Disease Prevention; Health Promotion (US) Office on Smoking and Health. The health consequences of smoking: 50 years of progress. A report of the Surgeon General. Atlanta (GA): US Centers for Disease Control and Prevention, 2014. https://www.ncbi.nlm.nih.gov/books/NBK179276 (viewed Mar 2021).
- 10. Paul CL, Tzelepis F, Boyes AW, et al. Continued smoking after a cancer diagnosis: a longitudinal study of intentions and attempts to quit. J Cancer Surviv 2019; 13: 687–694.
- 11. Chiuve SE, McCullough ML, Sacks FM, Rimm EB. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid‐lowering and antihypertensive medications. Circulation 2006; 114: 160–167.
- 12. Chiuve SE, Fung TT, Rexrode KM, et al. Adherence to a low‐risk, healthy lifestyle and risk of sudden cardiac death among women. JAMA 2011; 306: 62–69.
- 13. National Vascular Disease Prevention Alliance. Guidelines for the management of absolute cardiovascular disease risk. 2012. http://www.cvdcheck.org.au/pdf/Absolute_CVD_Risk_Full_Guidelines.pdf (viewed Mar 2021).
- 14. Chidwick K, Strongman H, Matthews A, et al. Statin use in cancer survivors versus the general population: cohort study using primary care data from the UK clinical practice research datalink. BMC Cancer 2018; 18: 1018.
Emily Banks is supported by a Principal Research Fellowship from the National Health and Medical Research Council.
No relevant disclosures.